Subject: Notice convening the 43rd Annual General Meeting (AGM) and the Annual Report for Financial Year 2024-2025. Dear Sir/ Ma'am, Pursuant to the Regulation 34(1) of SEBI (Listing ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Coral Laboratories Ltd has notified BSE about its 43rd Annual General Meeting scheduled for Friday, September 26, 2025 at 12:00 PM (IST), to be held via video conferencing. The AGM will consider adopting audited financial statements for FY 2024-25 and declaring a dividend of Rs. 1.5 per equity share (15% on face value of Rs. 10), totaling Rs. 53.59 lakh. Other agenda items include re-appointment of two directors (Mr. Girish Dhameja and Mr. Rajendrasinh Rana) retiring by rotation, appointment of M/s. S C Mehra & Associates LLP as statutory auditors for FY 2025-26 through the 48th AGM, ratification of cost auditor remuneration of Rs. 2.73 lakh for FY 2025-26, approval of up to Rs. 30 lakh per annum remuneration for Non-Executive Chairman Mrs. Sushma Kadkade, appointment of SARK & Associates LLP as secretarial auditor for five years (FY 2025-26 to FY 2029-30), amendment to the Memorandum of Association to expand business scope, and approval of remuneration up to Rs. 5 lakh per month for Ms. Meera Doshi as Head of Business Strategy for three years. E-voting will be available from September 22 to September 25, 2025, with the cut-off date set as September 19, 2025.
Routine AGM notice with standard agenda items. Shareholders on record as of September 19, 2025 will be eligible to vote and receive the declared Rs. 1.5 per share dividend. The proposed MOA amendment and new auditor/managment remuneration approvals are governance items requiring shareholder approval but unlikely to materially affect stock price.